/
1x
Advertisement

Shooting for a cure

An experimental vaccine may help stave off colon cancer
Add Maclean's(opens in a new tab)

A new vaccine may prevent people from developing colon cancer. Scientists at the University of Pittsburgh have already administered the shot to a dozen patients, and plan on inoculating another 50 study participants with the vaccine, which is still considered experimental. It seems to work by stimulating an immune response that fights the MUC1 protein found in precancerous growths, known as adenomas. That, in effect, would help the body attack abnormal cells, which would otherwise lead to colon cancer. If the vaccine works, it will also mean that at-risk patients won¹t have to rely on as many frequent and uncomfortable colonscopy tests.

ScienceDaily

Get the Best of Maclean’s straight to your inbox.

Sign up for news, commentary and analysis. Join 60,000+ Canadian readers.

By signing up, you agree to our terms of use and privacy policy. You may unsubscribe at any time.